University of Minnesota. Driven to Discover.
The drug may cut all-cause mortality in patients with severe C difficile infection.
The guidelines include testing for latent TB, which may affect as many as 13 million Americans.
In another breaking development, the CDC today urged pregnant women to avoid nonessential travel to 11 Southeast Asian countries.
The PATH Act would establish a new "limited population antibacterial drug approval pathway."
Hospital-acquired and ventilator-related pneumonia get a 7-day course, IDSA says.
Get CIDRAP news and other free newsletters.
Sign up now»
Unrestricted financial support provided by
Grant support for ASP provided by
CIDRAP - Center for Infectious Disease Research and PolicyOffice of the Vice President for Research, University of Minnesota, Minneapolis, MN
© 2019 Regents of the University of Minnesota. All rights reserved.The University of Minnesota is an equal opportunity educator and employer.